{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:22:50Z","timestamp":1788790970034,"version":"build-2803163510"},"reference-count":75,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001316","name":"Abbott","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.cpcardiol.2026.103428","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:08:41Z","timestamp":1786547321000},"page":"103428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Current status of cardiovascular risk factor control: are we meeting the targets?"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3999-1265","authenticated-orcid":false,"given":"Lucrecia Maria","family":"Burgos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Costabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Ramos","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Rub\u00e9n","family":"Micali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Teresa","family":"Koslowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Zamorano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2026.103428_bib0001","article-title":"Factors related to cardiovascular disease risk reduction in midlife and older women: a qualitative study","volume":"184","author":"Folta","year":"2024","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0002","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/CIRCRESAHA.116.309955","article-title":"Novel risk markers and risk assessments for cardiovascular disease","volume":"120","author":"Thomas","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0003","article-title":"Consensus on cardiovascular prevention in childhood and adolescence. Brief version. Recommendations","volume":"117","author":"Cook","year":"2019","journal-title":"Arch Argent Pediatr"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0004","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/07399330701723756","article-title":"More similarities than differences: an international comparison of CVD mortality and risk factors in women","volume":"29","author":"Gholizadeh","year":"2007","journal-title":"Health Care Women Int"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0005","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1016\/S2214-109X(17)30058-X","article-title":"Socioeconomic status and non-communicable disease behavioural risk factors in low-income and lower-middle-income countries: a systematic review","volume":"5","author":"Allen","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0006","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae646","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McCarthy","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0007","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1177\/2047487318825350","article-title":"Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry","volume":"26","author":"Kotseva","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0008","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0140-6736(25)01391-1","article-title":"Benefit-harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trials","volume":"406","author":"Guo","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0009","author":"Jones","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0010","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/HYPERTENSIONAHA.111.00633","article-title":"Sympathetic nervous system and hypertension","volume":"61","author":"Dibona","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0011","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/CIRCRESAHA.121.318082","article-title":"Pathophysiology of hypertension: the Mosaic theory and beyond","volume":"128","author":"Harrison","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0012","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/CIRCRESAHA.124.325439","article-title":"Epigenetic regulation of innate and adaptive immune cells in salt-sensitive hypertension","volume":"136","author":"Mutchler","year":"2025","journal-title":"Circ Res"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0013","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1007\/s40620-025-02406-2","article-title":"The role of renal denervation for the treatment of hypertension in patients with chronic kidney disease: a position paper of the Italian Society of Nephrology","volume":"38","author":"Feriozzi","year":"2025","journal-title":"J Nephrol"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0014","first-page":"e122","volume":"135","author":"Chan","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0015","doi-asserted-by":"crossref","first-page":"E143","DOI":"10.1161\/HYP.0000000000000232","article-title":"Implementation strategies to improve blood pressure control in the United States: a scientific statement from the American Heart Association and American Medical Association","volume":"80","author":"Abdalla","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0289715","article-title":"Concurrent exercise training induces additional benefits to hydrochlorothiazide: evidence for an improvement of autonomic control and oxidative stress in a model of hypertension and postmenopause","volume":"18","author":"Ferreira","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijchy.2020.100044","article-title":"Prevalence and control rates of hypertension in the USA: 2017\u20132018","volume":"6","author":"Chobufo","year":"2020","journal-title":"Int J Cardiol Hypertens"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0018","article-title":"Secondary prevention of cardiovascular disease: is it time for the polypill to be standard treatment?","volume":"55","author":"Marshall","year":"2025","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0019","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jamacardio.2024.4812","article-title":"Cost-effectiveness of a polypill for cardiovascular disease prevention in an underserved population","volume":"10","author":"Kohli-Lynch","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11739-019-02146-9","article-title":"Cost-effectiveness analysis of different hypertension management strategies in a community setting","volume":"15","author":"Zhang","year":"2020","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0021","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/jch.12499","article-title":"Resources for blood pressure screening programs in low resource settings: a guide from the World Hypertension League","volume":"17","author":"Mangat","year":"2015","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0022","article-title":"Lifestyle modifications to prevent and control hypertension. 2. Recommendations on obesity and weight loss","volume":"160","author":"Leiter","year":"1999","journal-title":"Can Hypertens Soc Can Coalit High Blood Press Prev Control Lab Cent Dis Control Health Can Heart Stroke Found Can CMAJ"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.896603","article-title":"Evaluation of the community-based hypertension management programs in China","volume":"10","author":"Hao","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0024","first-page":"571","article-title":"Community-based programs to improve prevention and management of hypertension: recent canadian experiences, challenges, and opportunities","volume":"29","author":"Kaczorowski","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0025","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/eurjpc\/zwaa047","article-title":"EU-wide cross-sectional observational study of lipid-modifying therapy use in secondary and primary care: the DAVINCI study","volume":"28","author":"Ray","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0026","article-title":"Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study","volume":"29","author":"Ray","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0027","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.athplu.2024.10.001","article-title":"Efficacy and safety of lipid-lowering therapies in combination with or without statin to reduce the cardiovascular risk: a systematic review of randomised controlled trials","volume":"58","author":"Iannuzzo","year":"2024","journal-title":"Atheroscler Plus"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0028","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0029","doi-asserted-by":"crossref","first-page":"e548","DOI":"10.1016\/j.jacl.2024.04.122","article-title":"Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES study","volume":"18","author":"Bittner","year":"2024","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0030","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","article-title":"CLEAR outcomes investigators. Bempedoic acid and cardiovascular outcomes in statin-intolerant patients","volume":"388","author":"Nissen","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.120479","article-title":"2025 Focused update of the 2019 ESC\/EAS Guidelines for the management of dyslipidaemias","volume":"409","author":"Mach","year":"2025","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0032","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s40256-024-00714-9","article-title":"Bempedoic Acid: a review in cardiovascular risk reduction in statin-intolerant patients","volume":"25","author":"McGuigan","year":"2025","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0033","doi-asserted-by":"crossref","DOI":"10.1007\/s11883-024-01248-w","article-title":"Ezetimibe: integrating established use with new evidence - a comprehensive review","volume":"27","author":"Olmastroni","year":"2025","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0034","article-title":"A systematic review and meta-analysis on the role of bempedoic acid in cardiovascular outcomes for patients with statin intolerance","volume":"16","author":"Serour","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0035","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","article-title":"ORION-10 and ORION-11 investigators. Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0036","first-page":"537","article-title":"Effect of sodium reduction based on the DASH diet on blood pressure in hypertensive patients with type 2 diabetes","volume":"39","author":"Mu","year":"2022","journal-title":"Nutr Hosp"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0037","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/HCO.0000000000000532","article-title":"The role of diet for prevention and management of hypertension","volume":"33","author":"Ozemek","year":"2018","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0038","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1056\/NEJM200101043440101","article-title":"Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet","volume":"344","author":"Sacks","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0039","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/advances\/nmaa041","article-title":"Dietary approaches to stop hypertension (DASH) diet and blood pressure reduction in adults with and without hypertension: a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Filippou","year":"2020","journal-title":"Adv Nutr"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0040","article-title":"Individual patient education for people with type 2 diabetes mellitus","volume":"2010","author":"Duke","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0041","article-title":"Quality improvement strategies for diabetes care: effects on outcomes for adults living with diabetes","volume":"2023","author":"Yogasingam","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0042","doi-asserted-by":"crossref","DOI":"10.1186\/s12875-025-02743-y","article-title":"The involvement of specialists in primary healthcare teams for managing diabetes: a systematic review and meta-analysis","volume":"26","author":"Li","year":"2025","journal-title":"BMC Prim Care"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0043","doi-asserted-by":"crossref","DOI":"10.1186\/s12875-024-02641-9","article-title":"Quality priorities related to the management of type 2 diabetes in primary care: results from the COMPAS + quality improvement collaborative","volume":"25","author":"Gaid","year":"2024","journal-title":"BMC Prim Care"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0044","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.123.067584","article-title":"Estimated lifetime cardiovascular, kidney, and mortality benefits of combination treatment with SGLT2 inhibitors, GLP-1 receptor agonists, and nonsteroidal MRA compared with conventional care in patients with type 2 diabetes and albuminuria","volume":"149","author":"Neuen","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0045","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076410","article-title":"Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis","volume":"384","author":"Yao","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes \u2013 state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0047","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-023-02035-8","article-title":"Impact of SGLT2 inhibitors on patient outcomes: a network meta-analysis","volume":"22","author":"Chen","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0048","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-022-01508-6","article-title":"Comparison of cardiovascular outcomes between SGLT2 inhibitors in diabetes mellitus","volume":"21","author":"Suzuki","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0049","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.2337\/dci24-0003","article-title":"Efficacy and safety of GLP-1 medicines for type 2 diabetes and obesity","volume":"47","author":"Drucker","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0050","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1093\/eurheartj\/ehad263","article-title":"Risk prediction in patients with diabetes: is SCORE 2D the perfect solution?","volume":"44","author":"Ryden","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0051","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1093\/eurheartj\/ehad260","article-title":"SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe","volume":"44","author":"Pennells","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0052","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/ALN.0000000000005534","article-title":"Diabetes mellitus in pregnancy: implications for obstetric anesthesia","volume":"143","author":"Rogers","year":"2025","journal-title":"Anesthesiology"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0053","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/jch.12638","article-title":"Diabetes and hypertension: a comparative review of current guidelines","volume":"18","author":"Cryer","year":"2016","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0054","first-page":"1212","article-title":"A diabetes care team\u2013role of diabetes specialists and certified diabetes educator","volume":"49","author":"Matsuoka","year":"2001","journal-title":"Rinsho Byori"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0055","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1111\/jan.14025","article-title":"A systematic review and meta-analysis on the effectiveness of education on medication adherence for patients with hypertension, hyperlipidaemia and diabetes","volume":"75","author":"Tan","year":"2019","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0056","first-page":"485","article-title":"Physician office-based diabetes care: comparison to guidelines for care","volume":"94","author":"Hermayer","year":"1998","journal-title":"J S C Med Assoc"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0057","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2174\/187221411794351879","article-title":"Hypoglycemic agents in the management of type 2 diabetes mellitus","volume":"5","author":"Ho","year":"2011","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0058","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1016\/j.jcjd.2015.09.090","article-title":"Impact of current and emerging glucose-lowering drugs on body weight in type 2 diabetes","volume":"39","author":"Lau","year":"2015","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0059","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00003495-200565030-00005","article-title":"Oral antidiabetic agents: current role in type 2 diabetes mellitus","volume":"65","author":"Krentz","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0060","doi-asserted-by":"crossref","first-page":"S318","DOI":"10.1016\/j.amepre.2007.09.008","article-title":"The tobacco epidemic in the United States","volume":"33","author":"Giovino","year":"2007","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0061","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev-publhealth-032315-021850","article-title":"One hundred years in the making: the global tobacco epidemic","volume":"37","author":"Wipfli","year":"2016","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0062","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.thorsurg.2013.01.009","article-title":"Tobacco smoking. The leading cause of preventable disease worldwide","volume":"23","author":"Samet","year":"2013","journal-title":"Thorac Surg Clin"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0063","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4082\/kjfm.2013.34.3.160","article-title":"Factors associated with persistent smoking after the diagnosis of cardiovascular disease","volume":"34","author":"Kim","year":"2013","journal-title":"Korean J Fam Med"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0064","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jacc.2003.12.047","article-title":"The pathophysiology of cigarette smoking and cardiovascular disease: an update","volume":"43","author":"Ambrose","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0065","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s13181-020-00772-w","article-title":"Review of health consequences of electronic cigarettes and the outbreak of electronic cigarette, or vaping, product use-associated lung injury","volume":"16","author":"Cao","year":"2020","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0066","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/tobaccocontrol-2020-056090","article-title":"Youth and young adult risk perceptions and behaviours in response to an outbreak of e-cigarette\/vaping-associated lung injury (EVALI) in the USA","volume":"31","author":"Kreslake","year":"2022","journal-title":"Tob Control"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0067","first-page":"87","article-title":"Electronic cigarettes and e-cigarette\/vaping product use associated lung injury (EVALI)","volume":"36","author":"Shinbashi","year":"2020","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0068","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.2105\/AJPH.91.9.1416","article-title":"The short-term impact of national smoke-free work place legislation on passive smoking and tobacco use","volume":"91","author":"Heloma","year":"2001","journal-title":"Am J Public Health"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0069","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/pubmed\/fdn062","article-title":"Changes in air quality and second-hand smoke exposure in hospitality sector businesses after introduction of the English smoke-free legislation","volume":"30","author":"Gotz","year":"2008","journal-title":"J Public Health (Bangk)"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0070","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3390\/ijerph6010246","article-title":"Smoke-free medical facility campus legislation: support, resistance, difficulties and cost","volume":"6","author":"Sheffer","year":"2009","journal-title":"Int J Env Res Public Health"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0071","article-title":"Cost analysis of community-based smoking cessation services in Vietnam: a cluster-randomized trial","volume":"14","author":"Quynh Mai","year":"2021","journal-title":"Health v Insights"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0072","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2019.00364","article-title":"Community-based smoking cessation programs: a way forward?","volume":"7","author":"Gesinde","year":"2019","journal-title":"Front Public Health"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0073","doi-asserted-by":"crossref","first-page":"i14","DOI":"10.1136\/tobaccocontrol-2012-050860","article-title":"Reducing the nicotine content to make cigarettes less addictive","volume":"22","author":"Benowitz","year":"2013","journal-title":"Tob Control"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0074","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.metabol.2018.09.005","article-title":"The epidemiology of obesity","volume":"92","author":"Chooi","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.cpcardiol.2026.103428_bib0075","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1001\/jamainternmed.2023.8526","article-title":"Approach to obesity treatment in primary care: a review","volume":"184","author":"Yanovski","year":"2024","journal-title":"JAMA Intern Med"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280626001672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280626001672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:25:31Z","timestamp":1788787531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280626001672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":75,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0146280626001672"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2026.103428","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current status of cardiovascular risk factor control: are we meeting the targets?","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2026.103428","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103428"}}